Abstract: The antibody of the present invention, which specifically reacts with the N-terminal or C-terminal partial peptide of TGR23-2 ligand, is useful in detecting and quantifying the TGR23-2 ligand. Moreover, it is useful as a preventing/treating agent and a diagnostic agent for cancer, etc.

Abstract: A malodorous component is eliminated using a catalytic composition comprising a phosphate of a tetravalent metal (titanium or other Group 4 elements of the Periodic Table of Elements), a hydroxide of a divalent metal (copper, zinc or other transition metal), and a photocatalyst. The photocatalyst includes sulfide-semiconductors, oxide-semiconductors and other photo-semiconductors, e.g. titanium oxide. The composition may further contain silicon dioxide and/or a silver component. The catalytic composition insures efficient elimination of not only acidic components and basic components but also neutral components over a long period, irrespective of with or without a light irradiation.

Abstract: The present invention relates to a monclonal antibody capable of suppressing the motility of cancer cells, a polypeptide recognizable by said anti-cancer antibody and its fragment peptides which is capable of suppressing the motility of cancer cells. The present invention also relates to a production and a use for preventing the matastasis of cancer thereof.